论文部分内容阅读
欧盟法律关于药物方面的主要改革已获欧洲议会核准,并将赋予基于伦敦的欧洲药物评估检测代理处(EMEA)以更大的权利。议事法规专家们(MEPs)同意代理处负责对含有新的作用成分的每一种药物进行验证。此项立法改革的目的在于使新开发的药物可同时在欧盟的
EU law The major drug reform has been approved by the European Parliament and will give the London-based European Agency for the Assessment and Testing of EMEA greater powers. MEPs agree that the agency is responsible for validating every drug that contains a new component of action. The purpose of this legislative reform is to enable newly developed drugs to be available in the EU at the same time